ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.83
0.43%
US Tech 100
17,173.20
1.85%
S&P 500
5,064.20
0.91%
US Dollar vs CAD
1.36642
-0.02%
Bitcoin
59,548.24
0.72%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Zynerba Pharmaceuticals Inc (ZYNE)

  7. Zynerba Pharmaceuticals Inc (ZYNE) News

ZYNE Zynerba Pharmaceuticals Inc

1.30
0.00 (0.00%)
May 01 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Zynerba Pharmaceuticals Inc ZYNE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 1.30 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.30 1.30
more quote information »

Recent News

Date Time Source Heading
2/08/202418:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/19/202315:48EDGAR2Form 15-12G - Securities registration termination [Section..
10/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
10/11/202309:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202309:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202309:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202309:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202308:27EDGAR2Form POS AM - Post-Effective amendments for registration..
10/11/202308:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
10/11/202307:56EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
10/11/202307:31EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
10/11/202307:17EDGAR2Form 8-K - Current report
10/11/202307:00PRNUSHARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA..
10/04/202316:29EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
10/04/202315:05GLOBEImportant Information for Zynerba Pharmaceuticals..
9/29/202308:00GLOBEZynerba Pharmaceuticals Stockholders Reminded to Tender..
9/27/202307:25EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
9/27/202307:12EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
9/27/202307:00PRNUSHARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO..
9/15/202307:00EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
9/14/202315:59EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
9/14/202315:16EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
9/14/202315:15GLOBEZynerba Pharmaceuticals Presents Positive Data from Phase 2..
9/14/202315:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/14/202315:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202315:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
8/29/202315:05EDGAR2Form 8-K - Current report
8/28/202308:05EDGAR2Form SC 14D9 - Solicitation, recommendation statements
8/28/202307:23EDGAR2Form SC TO-T - Tender offer statement by Third Party
8/24/202316:23EDGAR2Form SC 13D - General statement of acquisition of beneficial..
8/15/202315:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/14/202316:29EDGAR2Form SC TO-C - Written communication relating to an issuer..
8/14/202316:26EDGAR2Form SC TO-C - Written communication relating to an issuer..
8/14/202316:20EDGAR2Form SC14D9C - Written communication relating to third party..
8/14/202306:45EDGAR2Form SC14D9C - Written communication relating to third party..
8/14/202306:42EDGAR2Form 8-K - Current report
8/14/202306:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202306:30PRNUSHARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.
8/08/202315:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
8/08/202315:05GLOBEZynerba Pharmaceuticals Announces New Date for Reconvened..
7/25/202316:24EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
7/25/202316:18GLOBEZynerba Pharmaceuticals Announces New Date for Reconvened..
6/28/202315:21EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
6/28/202315:05GLOBEZynerba Pharmaceuticals Announces Further Adjournment of..
6/20/202306:00GLOBEZynerba Pharmaceuticals to Present at the H.C. Wainwright..
6/13/202315:05GLOBEZynerba Pharmaceuticals Announces Partial Adjournment of..
5/23/202306:00GLOBEZynerba Pharmaceuticals Announces Podium and Poster..
5/15/202306:00GLOBEZynerba Pharmaceuticals Reports First Quarter 2023 Financial..

Your Recent History

NASDAQ
ZYNE
Zynerba Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved